The Trump administration has approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program that kicks off January 1.
Related Posts
LeadingAge 2025: Improving the Flow of Data in Senior Care
Healthcare providers in the U.S. are taking steps toward a more comprehensive approach to care delivery that helps patients throughout a continuum of care. Ideally, […]
What Healthcare Marketers Must Know
AI Overviews were launched in the U.S. in May 2024, and their impact on analytics dashboards is still taking shape. While marketers and healthcare leaders […]
Senate Approves Deal to End Government Shutdown Amid Healthcare Funding Dispute
On Sunday, seven Senate Democrats and one independent voted to endorse a Republican agreement to reopen the US government. Senators approved a tentative deal to […]